Description of Lymphatic Damage in Encephalic Venous Thrombosis and Strictures in MRI a Reverse-recovery Sequence: a Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Using a new MRI sequence for the detection of lymph nods
研究概览
简要总结
Inclusion (J0):
- Information
- Verification of inclusion and non-inclusion criteria
- Collection of consent
- MRI examination with injection of contrast product as part of the treatment comprising the sequences:
T1 TFE 1.0 iso 3D FLAIR injected Injected elliptical venous angiography 0.4mm iso or less 3D SWIp multiecho 3D T1 injected FABIR iso without injection (added as part of care in case of suspected ASH or meningitis) FLAIR 1.0 without injection (added as part of care for suspected ASH or meningitis) T2 BFFE XD (added by search) FABIR iso injected (added by research) 3D PD T1 0.55 MSDE iso injected (added by research)
Clinical information (SRM on inclusion, on discharge and at 3 months and recurrence within the year) will be collected from the patient's medical file
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over 18 years of age
- •Performing an MRI injected as part of care for one of the following reasons:
- •suspicion of pathology likely to be associated with narrowing or obstruction of one or more venous sinuses (cerebral thrombophlebitis, tissue damage with venous extension, idiopathic HIC
- •venous narrowing or obstruction proven by one of the above pathologies, requiring as part of routine care an injected MRI (search for impact, monitoring, pre-therapeutic assessment or prognosis)
- •Express consent to participate in the study
- •Affiliate or beneficiary of a social security scheme
排除标准
- •Absolute contraindication to MRI
- •Patient benefiting from a legal protection measure
- •Pregnant or breastfeeding woman
结局指标
主要结局
Using a new MRI sequence for the detection of lymph nods
时间窗: 1 DAY
Inversion recovery pulse sequences in MRI will be used to detect lymph nods.
次要结局
未报告次要终点
